 | • レポートコード：QYR2104Z3941 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ムーコル症のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（コンピュータ断層撮影（CT）、磁気共鳴画像法（MRI）、組織生検、その他）、用途別市場規模（病院・クリニック、医療機関、研究機関、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ムーコル症の市場動向 ・企業の競争状況、市場シェア ・ムーコル症の種類別市場規模（コンピュータ断層撮影（CT）、磁気共鳴画像法（MRI）、組織生検、その他） ・ムーコル症の用途別市場規模（病院・クリニック、医療機関、研究機関、その他） ・ムーコル症の北米市場規模2016-2027（アメリカ、カナダ） ・ムーコル症のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ムーコル症のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ムーコル症の中南米市場規模2016-2027（メキシコ、ブラジル） ・ムーコル症の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、Biocon、Cadila Pharmaceuticals、Novartis、Merck、Roche、Bristol Myers Squibb、Pfizer） ・結論 |
Mucormycosis is any fungal infection caused by fungi in the order Mucorales. Generally, species in the Mucor, Rhizopus, Absidia, and Cunninghamella genera are most often implicated. The disease is often characterized by hyphae growing in and around blood vessels and can be potentially life-threatening in diabetic or severely immunocompromised individuals.
If mucormycosis is suspected, amphotericin B therapy should be immediately administered due to the rapid spread and high mortality rate of the disease. Amphotericin B is usually administered for an additional 4–6 weeks after initial therapy begins to ensure eradication of the infection. After administration of either amphotericin B or posaconazole, surgical removal of the “fungus ball” is indicated. The disease must be monitored carefully for any signs of reemergence.
Market Analysis and Insights: Global Mucormycosis Market
The global Mucormycosis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Mucormycosis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Mucormycosis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Mucormycosis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Mucormycosis market.
Global Mucormycosis Scope and Market Size
Mucormycosis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Mucormycosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Diagnosis and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Diagnosis
Computed Tomography (CT)
Magnetic resonance imaging (MRI)
Tissue Biopsy
Others
Segment by Application
Hospitals & Clinics
Medical Institutes
Research Organization
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
Biocon
Cadila Pharmaceuticals
Novartis
Merck
Roche
Bristol Myers Squibb
Pfizer
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mucormycosis Market Size Growth Rate by Diagnosis: 2016 VS 2021 VS 2027
1.2.2 Computed Tomography (CT)
1.2.3 Magnetic resonance imaging (MRI)
1.2.4 Tissue Biopsy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Mucormycosis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals & Clinics
1.3.3 Medical Institutes
1.3.4 Research Organization
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Mucormycosis Market Perspective (2016-2027)
2.2 Mucormycosis Growth Trends by Regions
2.2.1 Mucormycosis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Mucormycosis Historic Market Share by Regions (2016-2021)
2.2.3 Mucormycosis Forecasted Market Size by Regions (2022-2027)
2.3 Mucormycosis Industry Dynamic
2.3.1 Mucormycosis Market Trends
2.3.2 Mucormycosis Market Drivers
2.3.3 Mucormycosis Market Challenges
2.3.4 Mucormycosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mucormycosis Players by Revenue
3.1.1 Global Top Mucormycosis Players by Revenue (2016-2021)
3.1.2 Global Mucormycosis Revenue Market Share by Players (2016-2021)
3.2 Global Mucormycosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Mucormycosis Revenue
3.4 Global Mucormycosis Market Concentration Ratio
3.4.1 Global Mucormycosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mucormycosis Revenue in 2020
3.5 Mucormycosis Key Players Head office and Area Served
3.6 Key Players Mucormycosis Product Solution and Service
3.7 Date of Enter into Mucormycosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Mucormycosis Breakdown Data by Diagnosis
4.1 Global Mucormycosis Historic Market Size by Diagnosis (2016-2021)
4.2 Global Mucormycosis Forecasted Market Size by Diagnosis (2022-2027)
5 Mucormycosis Breakdown Data by Application
5.1 Global Mucormycosis Historic Market Size by Application (2016-2021)
5.2 Global Mucormycosis Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Mucormycosis Market Size (2016-2027)
6.2 North America Mucormycosis Market Size by Diagnosis
6.2.1 North America Mucormycosis Market Size by Diagnosis (2016-2021)
6.2.2 North America Mucormycosis Market Size by Diagnosis (2022-2027)
6.2.3 North America Mucormycosis Market Size by Diagnosis (2016-2027)
6.3 North America Mucormycosis Market Size by Application
6.3.1 North America Mucormycosis Market Size by Application (2016-2021)
6.3.2 North America Mucormycosis Market Size by Application (2022-2027)
6.3.3 North America Mucormycosis Market Size by Application (2016-2027)
6.4 North America Mucormycosis Market Size by Country
6.4.1 North America Mucormycosis Market Size by Country (2016-2021)
6.4.2 North America Mucormycosis Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Mucormycosis Market Size (2016-2027)
7.2 Europe Mucormycosis Market Size by Diagnosis
7.2.1 Europe Mucormycosis Market Size by Diagnosis (2016-2021)
7.2.2 Europe Mucormycosis Market Size by Diagnosis (2022-2027)
7.2.3 Europe Mucormycosis Market Size by Diagnosis (2016-2027)
7.3 Europe Mucormycosis Market Size by Application
7.3.1 Europe Mucormycosis Market Size by Application (2016-2021)
7.3.2 Europe Mucormycosis Market Size by Application (2022-2027)
7.3.3 Europe Mucormycosis Market Size by Application (2016-2027)
7.4 Europe Mucormycosis Market Size by Country
7.4.1 Europe Mucormycosis Market Size by Country (2016-2021)
7.4.2 Europe Mucormycosis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Mucormycosis Market Size (2016-2027)
8.2 Asia-Pacific Mucormycosis Market Size by Diagnosis
8.2.1 Asia-Pacific Mucormycosis Market Size by Diagnosis (2016-2021)
8.2.2 Asia-Pacific Mucormycosis Market Size by Diagnosis (2022-2027)
8.2.3 Asia-Pacific Mucormycosis Market Size by Diagnosis (2016-2027)
8.3 Asia-Pacific Mucormycosis Market Size by Application
8.3.1 Asia-Pacific Mucormycosis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Mucormycosis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Mucormycosis Market Size by Application (2016-2027)
8.4 Asia-Pacific Mucormycosis Market Size by Region
8.4.1 Asia-Pacific Mucormycosis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Mucormycosis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Mucormycosis Market Size (2016-2027)
9.2 Latin America Mucormycosis Market Size by Diagnosis
9.2.1 Latin America Mucormycosis Market Size by Diagnosis (2016-2021)
9.2.2 Latin America Mucormycosis Market Size by Diagnosis (2022-2027)
9.2.3 Latin America Mucormycosis Market Size by Diagnosis (2016-2027)
9.3 Latin America Mucormycosis Market Size by Application
9.3.1 Latin America Mucormycosis Market Size by Application (2016-2021)
9.3.2 Latin America Mucormycosis Market Size by Application (2022-2027)
9.3.3 Latin America Mucormycosis Market Size by Application (2016-2027)
9.4 Latin America Mucormycosis Market Size by Country
9.4.1 Latin America Mucormycosis Market Size by Country (2016-2021)
9.4.2 Latin America Mucormycosis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mucormycosis Market Size (2016-2027)
10.2 Middle East & Africa Mucormycosis Market Size by Diagnosis
10.2.1 Middle East & Africa Mucormycosis Market Size by Diagnosis (2016-2021)
10.2.2 Middle East & Africa Mucormycosis Market Size by Diagnosis (2022-2027)
10.2.3 Middle East & Africa Mucormycosis Market Size by Diagnosis (2016-2027)
10.3 Middle East & Africa Mucormycosis Market Size by Application
10.3.1 Middle East & Africa Mucormycosis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Mucormycosis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Mucormycosis Market Size by Application (2016-2027)
10.4 Middle East & Africa Mucormycosis Market Size by Country
10.4.1 Middle East & Africa Mucormycosis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Mucormycosis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Mucormycosis Introduction
11.1.4 Abbott Laboratories Revenue in Mucormycosis Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Biocon
11.2.1 Biocon Company Details
11.2.2 Biocon Business Overview
11.2.3 Biocon Mucormycosis Introduction
11.2.4 Biocon Revenue in Mucormycosis Business (2016-2021)
11.2.5 Biocon Recent Development
11.3 Cadila Pharmaceuticals
11.3.1 Cadila Pharmaceuticals Company Details
11.3.2 Cadila Pharmaceuticals Business Overview
11.3.3 Cadila Pharmaceuticals Mucormycosis Introduction
11.3.4 Cadila Pharmaceuticals Revenue in Mucormycosis Business (2016-2021)
11.3.5 Cadila Pharmaceuticals Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Mucormycosis Introduction
11.4.4 Novartis Revenue in Mucormycosis Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Mucormycosis Introduction
11.5.4 Merck Revenue in Mucormycosis Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Mucormycosis Introduction
11.6.4 Roche Revenue in Mucormycosis Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Bristol Myers Squibb
11.7.1 Bristol Myers Squibb Company Details
11.7.2 Bristol Myers Squibb Business Overview
11.7.3 Bristol Myers Squibb Mucormycosis Introduction
11.7.4 Bristol Myers Squibb Revenue in Mucormycosis Business (2016-2021)
11.7.5 Bristol Myers Squibb Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Mucormycosis Introduction
11.8.4 Pfizer Revenue in Mucormycosis Business (2016-2021)
11.8.5 Pfizer Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Mucormycosis Market Size Growth Rate by Diagnosis (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Computed Tomography (CT)
Table 3. Key Players of Magnetic resonance imaging (MRI)
Table 4. Key Players of Tissue Biopsy
Table 5. Key Players of Others
Table 6. Global Mucormycosis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Mucormycosis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Mucormycosis Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Mucormycosis Market Share by Regions (2016-2021)
Table 10. Global Mucormycosis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Mucormycosis Market Share by Regions (2022-2027)
Table 12. Mucormycosis Market Trends
Table 13. Mucormycosis Market Drivers
Table 14. Mucormycosis Market Challenges
Table 15. Mucormycosis Market Restraints
Table 16. Global Mucormycosis Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Mucormycosis Market Share by Players (2016-2021)
Table 18. Global Top Mucormycosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mucormycosis as of 2020)
Table 19. Ranking of Global Top Mucormycosis Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Mucormycosis Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Mucormycosis Product Solution and Service
Table 23. Date of Enter into Mucormycosis Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Mucormycosis Market Size by Diagnosis (2016-2021) (US$ Million)
Table 26. Global Mucormycosis Revenue Market Share by Diagnosis (2016-2021)
Table 27. Global Mucormycosis Forecasted Market Size by Diagnosis (2022-2027) (US$ Million)
Table 28. Global Mucormycosis Revenue Market Share by Diagnosis (2022-2027) & (US$ Million)
Table 29. Global Mucormycosis Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Mucormycosis Revenue Market Share by Application (2016-2021)
Table 31. Global Mucormycosis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Mucormycosis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Mucormycosis Market Size by Diagnosis (2016-2021) (US$ Million)
Table 34. North America Mucormycosis Market Size by Diagnosis (2022-2027) & (US$ Million)
Table 35. North America Mucormycosis Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Mucormycosis Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Mucormycosis Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Mucormycosis Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Mucormycosis Market Size by Diagnosis (2016-2021) (US$ Million)
Table 40. Europe Mucormycosis Market Size by Diagnosis (2022-2027) & (US$ Million)
Table 41. Europe Mucormycosis Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Mucormycosis Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Mucormycosis Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Mucormycosis Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Mucormycosis Market Size by Diagnosis (2016-2021) (US$ Million)
Table 46. Asia-Pacific Mucormycosis Market Size by Diagnosis (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Mucormycosis Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Mucormycosis Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Mucormycosis Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Mucormycosis Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Mucormycosis Market Size by Diagnosis (2016-2021) (US$ Million)
Table 52. Latin America Mucormycosis Market Size by Diagnosis (2022-2027) & (US$ Million)
Table 53. Latin America Mucormycosis Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Mucormycosis Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Mucormycosis Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Mucormycosis Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Mucormycosis Market Size by Diagnosis (2016-2021) (US$ Million)
Table 58. Middle East & Africa Mucormycosis Market Size by Diagnosis (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Mucormycosis Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Mucormycosis Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Mucormycosis Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Mucormycosis Market Size by Country (2022-2027) & (US$ Million)
Table 63. Abbott Laboratories Company Details
Table 64. Abbott Laboratories Business Overview
Table 65. Abbott Laboratories Mucormycosis Product
Table 66. Abbott Laboratories Revenue in Mucormycosis Business (2016-2021) & (US$ Million)
Table 67. Abbott Laboratories Recent Development
Table 68. Biocon Company Details
Table 69. Biocon Business Overview
Table 70. Biocon Mucormycosis Product
Table 71. Biocon Revenue in Mucormycosis Business (2016-2021) & (US$ Million)
Table 72. Biocon Recent Development
Table 73. Cadila Pharmaceuticals Company Details
Table 74. Cadila Pharmaceuticals Business Overview
Table 75. Cadila Pharmaceuticals Mucormycosis Product
Table 76. Cadila Pharmaceuticals Revenue in Mucormycosis Business (2016-2021) & (US$ Million)
Table 77. Cadila Pharmaceuticals Recent Development
Table 78. Novartis Company Details
Table 79. Novartis Business Overview
Table 80. Novartis Mucormycosis Product
Table 81. Novartis Revenue in Mucormycosis Business (2016-2021) & (US$ Million)
Table 82. Novartis Recent Development
Table 83. Merck Company Details
Table 84. Merck Business Overview
Table 85. Merck Mucormycosis Product
Table 86. Merck Revenue in Mucormycosis Business (2016-2021) & (US$ Million)
Table 87. Merck Recent Development
Table 88. Roche Company Details
Table 89. Roche Business Overview
Table 90. Roche Mucormycosis Product
Table 91. Roche Revenue in Mucormycosis Business (2016-2021) & (US$ Million)
Table 92. Roche Recent Development
Table 93. Bristol Myers Squibb Company Details
Table 94. Bristol Myers Squibb Business Overview
Table 95. Bristol Myers Squibb Mucormycosis Product
Table 96. Bristol Myers Squibb Revenue in Mucormycosis Business (2016-2021) & (US$ Million)
Table 97. Bristol Myers Squibb Recent Development
Table 98. Pfizer Company Details
Table 99. Pfizer Business Overview
Table 100. Pfizer Revenue in Mucormycosis Business (2016-2021) & (US$ Million)
Table 101. Pfizer Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mucormycosis Market Share by Diagnosis: 2020 VS 2027
Figure 2. Computed Tomography (CT) Features
Figure 3. Magnetic resonance imaging (MRI) Features
Figure 4. Tissue Biopsy Features
Figure 5. Others Features
Figure 6. Global Mucormycosis Market Share by Application: 2020 VS 2027
Figure 7. Hospitals & Clinics Case Studies
Figure 8. Medical Institutes Case Studies
Figure 9. Research Organization Case Studies
Figure 10. Others Case Studies
Figure 11. Mucormycosis Report Years Considered
Figure 12. Global Mucormycosis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Mucormycosis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Mucormycosis Market Share by Regions: 2020 VS 2027
Figure 15. Global Mucormycosis Market Share by Regions (2022-2027)
Figure 16. Global Mucormycosis Market Share by Players in 2020
Figure 17. Global Top Mucormycosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mucormycosis as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Mucormycosis Revenue in 2020
Figure 19. Global Mucormycosis Revenue Market Share by Diagnosis (2016-2021)
Figure 20. Global Mucormycosis Revenue Market Share by Diagnosis (2022-2027)
Figure 21. North America Mucormycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Mucormycosis Market Share by Diagnosis (2016-2027)
Figure 23. North America Mucormycosis Market Share by Application (2016-2027)
Figure 24. North America Mucormycosis Market Share by Country (2016-2027)
Figure 25. United States Mucormycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Mucormycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Mucormycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Mucormycosis Market Share by Diagnosis (2016-2027)
Figure 29. Europe Mucormycosis Market Share by Application (2016-2027)
Figure 30. Europe Mucormycosis Market Share by Country (2016-2027)
Figure 31. Germany Mucormycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Mucormycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Mucormycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Mucormycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Mucormycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Mucormycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Mucormycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Mucormycosis Market Share by Diagnosis (2016-2027)
Figure 39. Asia-Pacific Mucormycosis Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Mucormycosis Market Share by Region (2016-2027)
Figure 41. China Mucormycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Mucormycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Mucormycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Mucormycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Mucormycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Mucormycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Mucormycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Mucormycosis Market Share by Diagnosis (2016-2027)
Figure 49. Latin America Mucormycosis Market Share by Application (2016-2027)
Figure 50. Latin America Mucormycosis Market Share by Country (2016-2027)
Figure 51. Mexico Mucormycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Mucormycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Mucormycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Mucormycosis Market Share by Diagnosis (2016-2027)
Figure 55. Middle East & Africa Mucormycosis Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Mucormycosis Market Share by Country (2016-2027)
Figure 57. Turkey Mucormycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Mucormycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Mucormycosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Abbott Laboratories Revenue Growth Rate in Mucormycosis Business (2016-2021)
Figure 61. Biocon Revenue Growth Rate in Mucormycosis Business (2016-2021)
Figure 62. Cadila Pharmaceuticals Revenue Growth Rate in Mucormycosis Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Mucormycosis Business (2016-2021)
Figure 64. Merck Revenue Growth Rate in Mucormycosis Business (2016-2021)
Figure 65. Roche Revenue Growth Rate in Mucormycosis Business (2016-2021)
Figure 66. Bristol Myers Squibb Revenue Growth Rate in Mucormycosis Business (2016-2021)
Figure 67. Pfizer Revenue Growth Rate in Mucormycosis Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界の磁気共鳴画像（MRI）市場規模・現状・予測（2021年-2027年） We can use magnetic resonance imaging (MRI) to provide 2- or 3-D images of the brain for the study of its anatomy, function, or molecular processes... or a combination of all three. The nice thing about MRI is that a researcher can chose whether the focus should be anatomical with a little bit of fu…- 世界の単一光子放射断層撮影（SPECT）市場規模・現状・予測（2021年-2027年） Preclinical SPECT imaging uses gamma rays to image rodent models of disease and is often combined with CT scans and PET imaging to generate quantifiable data on therapeutic compound binding and brain function. Market Analysis and Insights: Global Preclinical Single Photon Emission Computed Tomograph…
- 世界の単一光子放射型コンピュータ断層撮影（SPECT）システム市場規模・現状・予測（2021年-2027年） Single-photon emission computed tomography (CT) is a radioisotope CT scan and belongs to the category of nuclear medicine. The imaging principle is a combination of radionuclide development and CT three-dimensional imaging technology, which can show the distribution of radioisotopes in different lay…
- 世界の冠血流予備量比コンピュータ断層撮影（FFR-CT）市場規模・現状・予測（2021年-2027年） Fractional flow reserve-computed tomography (FFR-CT) is an important technology to measurements for hemodynamic flow through the coronary arteries with non-invasive method. Moreover, the technology is procuring momentum and private insurance companies as well as Centers for Medicare and Medicaid Ser…
- 世界の前臨床脳画像市場規模・現状・予測（2021年-2027年） Preclinical imaging is a technique used to monitor animals for research purposes such as in new drug development. Preclinical imaging includes many different imaging modalities, in which only few are suitable for imaging small animals, and others can be used in large animals. Market Analysis and Ins…